GALCANEZUMAB

UNII: 55KHL3P693
Preferred Substance Name: GALCANEZUMAB

1578199-75-3
EMGALITY
GALCANEZUMAB [INN]
GALCANEZUMAB [JAN]
GALCANEZUMAB [MI]
GALCANEZUMAB [USAN]
GALCANEZUMAB [WHO-DD]
GALCANEZUMAB GNLM [WHO-DD]
GALCANEZUMAB-GNLM
GALCANEZUMAB-GNLM [PURPLE BOOK CDER]
IMMUNOGLOBULIN G4, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE) (HUMAN-MUS MUSCULUS CLONE III HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS CLONE III .KAPPA.-CHAIN, DIMER
LY2951742
LY-2951742

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

GALCANEZUMAB

Synonyms and Mappings

Resources

Note